Emergent says it has disposed of spoilt COVID-19 vaccine batch

April 1, 2021 7:32 PM EDT

FILE PHOTO: A nurse draws from a vial of Johnson & Johnson coronavirus disease (COVID-19) vaccine, in Los Angeles, California, U.S., March 25, 2021. REUTERS/Lucy Nicholson/File Photo


News and research before you hear about it on CNBC and others. Claim your 1-week free trial to StreetInsider Premium here.

(Reuters) - Johnson & Johnson's manufacturing partner Emergent Biosolutions said on Thursday that it had discarded the single batch of COVID-19 drug substance that did not meet specifications.

J&J on Wednesday said it had found a problem with a batch of the drug substance for its COVID-19 vaccine being produced at Emergent's site in Baltimore, Maryland.

The New York Times reported on Wednesday that about 15 million doses were ruined, without citing a source.

"Discarding a batch of bulk drug substance, while disappointing, does occasionally happen during vaccine manufacturing, which is a complex and multi-step biological process," Emergent said.

(Reporting by Dania Nadeem in Bengaluru; Editing by Anil D'Silva)



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Reuters